MELBOURNE, FL--(Marketwired - Nov 15, 2016) - First Choice Healthcare Solutions, Inc. (
Financial Highlights for the Comparable Nine Month Reporting Periods in 2016 and 2015, respectively:
- Total revenues up 72% to $22.56 million from $13.12 million
- Non-GAAP adjusted EBITDA* increased to $3.51 million from $2.62 million
- Notwithstanding the one-time $9.21 million gain from the sale of Marina Towers and other property and improvements, net income attributable to First Choice totaled $1.05 million, or $0.04 earnings per diluted share, compared to approximately $165,200, or $0.01 earnings per diluted share
Financial Highlights for the Comparable Three Month Reporting Periods in 2016 and 2015, respectively:
- Total revenues increased 22% to $7.70 million, up from $6.29 million
- Non-GAAP adjusted EBITDA* totaled $1.45 million, compared to $1.85 million
- Net income attributable to First Choice totaled approximately $545,000, or $0.02 earnings per diluted share, compared to approximately $631,281, or $0.03 earnings per diluted share
As of September 30, 2016, cash totaled $6.59 million, accounts receivable were $9.48 million and total stockholders' equity attributable to First Choice was $13.41 million. This compared to cash of $1.60 million, restricted cash of $360,000, accounts receivable of $6.62 million and total stockholders' equity attributable to First Choice of $2.12 million as of the end of December 2015.
Chris Romandetti, President and Chief Executive Officer of First Choice, stated, "While we are very pleased with our success in perpetuating revenue growth year-over-year, we are particularly gratified that our strategies to strengthen operating margins on total revenues has also continued to be positively impactful. Moreover, recruitment of new best-in-class physicians to our Space Coast, Florida care delivery platform continues to advance very well. Expansion initiatives being implemented in our ancillary services channels are also moving forward, while our Medical Centers of Excellence continue to sustain and further strengthen our overall profitability. And, given First Choice's strong working capital position, we are well positioned to assess and pursue a broad range of non-dilutive options for capital to finance even more dynamic growth in the future."
"All things considered, we are very pleased with our year-to-date progress. Looking ahead, we intend to persist in executing smart, purpose-driven business-building strategies that will allow us to achieve even more pronounced revenue and earnings growth in the coming year while notably enhancing sustainable long term value for our fellow shareholders," concluded Romandetti.
Public Conference Call & Webcast
First Choice's executive management team will host a conference this morning, beginning at 11:00 AM. Participants can register and access the conference call by dialing toll-free 866-682-6100. The conference call will also be webcasted, which can be accessed through First Choice's investor relations website by navigating to http://ir.myfchs.com/ and clicking on "Third Quarter 2016 Conference Call and Webcast." Participants will be required to register to access the call. For those who cannot listen to the live broadcast, a replay will be available shortly after the call on the investor relations page of First Choice's website, found at http://ir.myfchs.com/.
*About Non-GAAP Financial Measures
To supplement our consolidated financial statements, which are prepared and presented in accordance with GAAP, we use non-GAAP EBITDA, which is factored by adding back any non-cash or non-recurring gain or expense to the Net Income Attributable to First Choice. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. We use this non-GAAP financial measures for financial and operational decision-making and as a means to evaluate period-to-period comparisons. Our management believes that this non-GAAP financial measure provides meaningful supplemental information regarding our performance and liquidity by excluding certain items that may not be indicative of our recurring core business operating results. We believe that both management and investors benefit from referring to this non-GAAP financial measure in assessing our performance and when planning, forecasting, and analyzing future periods. This non-GAAP financial measure also facilitates management's internal comparisons to our historical performance and liquidity. We believe this non-GAAP financial measure is useful to investors both because they allow for greater transparency with respect to a key metric used by management in its financial and operational decision-making. For more information on this non-GAAP financial measure, please see the table captioned "Reconciliation of Non-GAAP Adjusted EBITDA Performance."
For additional details relating to First Choice's third quarter 2016 results, please refer to the Interim Report on Form 10-Q filed with the U.S. Securities and Exchange Commission and found at www.sec.gov.
FIRST CHOICE HEALTHCARE SOLUTIONS, INC. | |||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||
September 30, | December 31, | ||||||||
2016 | 2015 | ||||||||
(unaudited) | |||||||||
ASSETS | |||||||||
Current assets | |||||||||
Cash (amounts related to VIE of $1,445,090 and $1,556,303) | $ | 6,591,035 | $ | 1,594,998 | |||||
Cash-restricted | - | 359,414 | |||||||
Accounts receivable, net (amounts related to VIE of $5,558,273 and $4,544,308) | 9,477,069 | 6,623,894 | |||||||
Employee loans (amounts related to VIE of $509,350 and $636,293) | 783,009 | 672,293 | |||||||
Prepaid and other current assets (amounts related to VIE of $269,352 and $183,465) | 446,721 | 316,773 | |||||||
Capitalized financing costs, current portion (amounts related to VIE of $-0- and $1,317) | - | 39,533 | |||||||
Total current assets | 17,297,834 | 9,606,905 | |||||||
Property, plant and equipment, net of accumulated depreciation of $1,065,517 and $3,075,648 (amounts related to VIE of $717,557 and $773,808) | 2,629,309 | 8,613,502 | |||||||
Other assets | |||||||||
Goodwill (amount relating to VIE of $899,465) | 899,465 | 899,465 | |||||||
Deferred costs, net of amortization of $457,079 and $215,096 | 2,769,348 | 3,011,331 | |||||||
Patient list, net of accumulated amortization of $90,000 and $75,000 | 210,000 | 225,000 | |||||||
Patents, net of accumulated amortization of $52,525 and $38,200 | 233,975 | 248,300 | |||||||
Investments (amounts related to VIE of $22,005 and $16,914) | 22,005 | 16,914 | |||||||
Deferred tax asset | 181,029 | - | |||||||
Deposits | 2,571 | 2,571 | |||||||
Total other assets | 4,318,393 | 4,403,581 | |||||||
Total assets | $ | 24,245,536 | $ | 22,623,988 | |||||
LIABILITIES AND EQUITY | |||||||||
Current liabilities | |||||||||
Accounts payable and accrued expenses (amounts related to VIE of $1,751,197 and $2,319,056) | $ | 2,827,742 | $ | 3,937,244 | |||||
Accounts payable, related party (amount related to VIE of $251,588) | 251,588 | 251,588 | |||||||
Stock-based payable | 253,991 | 1,198,900 | |||||||
Advances | - | 43,082 | |||||||
AMT tax payable | 181,029 | - | |||||||
Settlement payable | - | 600,000 | |||||||
Line of credit, short term (amount related to VIE of $439,524 and $416,888) | 2,939,524 | 2,566,888 | |||||||
Note payable, related party, current portion (amount related to VIE of $-0- and $428,645) | - | 428,645 | |||||||
Notes payable, current portion (amount related to VIE of $1,021 and $10,341) | 517,666 | 7,652,941 | |||||||
Unearned revenue | 43,650 | 42,704 | |||||||
Deferred rent, short term portion (amount related to VIE of $237,620 and $118,810) | 237,620 | 118,810 | |||||||
Total current liabilities | 7,252,810 | 16,840,802 | |||||||
Long term debt: | |||||||||
Deposits held | 41,930 | 67,432 | |||||||
Notes payable, long term portion | 143,856 | 535,822 | |||||||
Deferred rent, long term portion (amount related to VIE of $2,200,603 and $2,141,199) | 2,253,060 | 2,141,199 | |||||||
Total long term debt | 2,438,846 | 2,744,453 | |||||||
Total liabilities | 9,691,656 | 19,585,255 | |||||||
Equity | |||||||||
Preferred stock, $0.01 par value; 1,000,000 shares authorized, Nil issued and outstanding | - | - | |||||||
Common stock, $0.001 par value; 100,000,000 shares authorized, 24,238,613 and 22,867,626 shares issued and outstanding as of September 30, 2016 and December 31, 2015, respectively | 24,239 | 22,868 | |||||||
Common stock subscription | - | 175,000 | |||||||
Additional paid-in capital | 22,393,921 | 21,196,792 | |||||||
Accumulated deficit | (9,009,899 | ) | (19,274,917 | ) | |||||
Total stockholders' equity attributable to First Choice Healthcare Solutions, Inc. | 13,408,261 | 2,119,743 | |||||||
Non-controlling interest (note 14) | 1,145,619 | 918,990 | |||||||
Total equity | 14,553,880 | 3,038,733 | |||||||
Total liabilities and equity | $ | 24,245,536 | $ | 22,623,988 | |||||
FIRST CHOICE HEALTHCARE SOLUTIONS, INC | |||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||||||||||
(unaudited) | |||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||
2016 | 2015 | 2016 | 2015 | ||||||||||||||
Revenues: | |||||||||||||||||
Patient Service Revenue | $ | 7,403,084 | $ | 5,775,986 | $ | 21,571,205 | $ | 11,871,574 | |||||||||
Provision for bad debts | (319,319 | ) | - | (849,037 | ) | (51,485 | ) | ||||||||||
Net patient service revenue less provision for bad debts | 7,083,765 | 5,775,986 | 20,722,168 | 11,820,089 | |||||||||||||
Rental Revenue | 585,978 | 516,136 | 1,842,428 | 1,301,515 | |||||||||||||
Total Revenue | 7,669,743 | 6,292,122 | 22,564,596 | 13,121,604 | |||||||||||||
Operating expenses: | |||||||||||||||||
Salaries and benefits | 3,158,172 | 2,240,109 | 9,077,783 | 5,311,710 | |||||||||||||
Other operating expenses | 1,405,489 | 670,923 | 4,166,139 | 1,685,830 | |||||||||||||
General and administrative | 2,404,996 | 2,234,647 | 7,346,614 | 4,437,801 | |||||||||||||
Depreciation and amortization | 195,821 | 273,263 | 631,571 | 558,189 | |||||||||||||
Total operating expenses | 7,164,478 | 5,418,942 | 21,222,107 | 11,993,530 | |||||||||||||
Net income from operations | 505,265 | 873,180 | 1,342,489 | 1,128,074 | |||||||||||||
Other income (expense): | |||||||||||||||||
Gain on sale of property and improvements | - | - | 9,212,346 | - | |||||||||||||
Miscellaneous income (expense) | 135,544 | (18,400 | ) | 241,213 | 22,719 | ||||||||||||
Amortization financing costs | - | (20,592 | ) | (15,654 | ) | (60,507 | ) | ||||||||||
Interest expense, net | (56,560 | ) | (202,907 | ) | (288,748 | ) | (925,045 | ) | |||||||||
Total other expense | 78,984 | (241,899 | ) | 9,149,157 | (962,833 | ) | |||||||||||
Net income before provision for income taxes | 584,249 | 631,281 | 10,491,646 | 165,241 | |||||||||||||
Income taxes (benefit) | - | - | - | - | |||||||||||||
Net income | 584,249 | 631,281 | 10,491,646 | 165,241 | |||||||||||||
Non-controlling interest | (39,309 | ) | - | (226,628 | ) | - | |||||||||||
NET INCOME ATTRIBUTABLE TO FIRST CHOICE HEALTHCARE SOLUTIONS, INC. | $ | 544,940 | $ | 631,281 | $ | 10,265,018 | $ | 165,241 | |||||||||
Net income per common share, basic | $ | 0.02 | $ | 0.03 | $ | 0.44 | $ | 0.01 | |||||||||
Net income per common share, diluted | $ | 0.02 | $ | 0.03 | $ | 0.39 | $ | 0.01 | |||||||||
Weighted average number of common shares outstanding, basic | 24,238,613 | 20,958,877 | 23,664,723 | 19,249,783 | |||||||||||||
Weighted average number of common shares outstanding, diluted | 27,751,946 | 22,992,211 | 26,998,057 | 21,583,117 |
FIRST CHOICE HEALTHCARE SOLUTIONS, INC | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||
(unaudited) | |||||||||
Nine months ended September 30, | |||||||||
2016 | 2015 | ||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||
Net Income | $ | 10,491,646 | $ | 165,241 | |||||
Adjustments to reconcile net income to cash (used in) provided by operating activities: | |||||||||
Depreciation and amortization | 631,571 | 558,189 | |||||||
Amortization of financing costs | 15,654 | 60,507 | |||||||
Bad debt expense | 849,037 | 51,485 | |||||||
Gain on sale of property | (9,212,346 | ) | - | ||||||
Common stock issued in connection with loan extension | - | 227,000 | |||||||
Note payable issued in settlement of litigation | - | 50,749 | |||||||
Stock-based compensation | 668,591 | 859,991 | |||||||
Changes in operating assets and liabilities: | |||||||||
Accounts receivable | (3,702,212 | ) | (1,678,545 | ) | |||||
Prepaid expenses and other | (129,948 | ) | 203,699 | ||||||
Restricted funds | 359,414 | (77,378 | ) | ||||||
Employee loans | (110,716 | ) | (19,728 | ) | |||||
Accounts payable and accrued expenses | (1,718,516 | ) | 140,254 | ||||||
Settlement payable | (600,000 | ) | - | ||||||
Deposits | (25,502 | ) | (5,469 | ) | |||||
Deferred rent | 230,671 | 39,603 | |||||||
Unearned income | 946 | 3,941 | |||||||
Net cash (used in) provided by operating activities | (2,251,710 | ) | 579,539 | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||
Cash from variable interest entity | - | 679,673 | |||||||
Proceeds from sale of property | 15,113,497 | - | |||||||
Payment of acquisition deposit | - | (141,352 | ) | ||||||
Purchase of equipment | (239,418 | ) | (92,609 | ) | |||||
Net cash provided by investing activities | 14,874,079 | 445,712 | |||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||
(Repayments) proceeds from advances | (43,082 | ) | 431,406 | ||||||
Payments on lines of credit | 372,636 | (331,162 | ) | ||||||
Net payments on notes payable | (7,955,886 | ) | (653,023 | ) | |||||
Net cash used in financing activities | (7,626,332 | ) | (552,779 | ) | |||||
Net increase in cash and cash equivalents | 4,996,037 | 472,472 | |||||||
Cash and cash equivalents, beginning of period | 1,594,998 | 279,087 | |||||||
Cash and cash equivalents, end of period | $ | 6,591,035 | $ | 751,559 | |||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: | |||||||||
Cash paid during the period for interest | $ | 288,748 | $ | 925,045 | |||||
Cash paid during the period for taxes | $ | - | $ | - | |||||
Supplemental Disclosure on non-cash investing and financing activities: | |||||||||
Common stock issued in settlement of accrued expenses | $ | 481,900 | $ | 15,000 | |||||
Common stock issued for future services | $ | - | $ | 1,153,777 | |||||
Common stock issued in settlement of related party advances | $ | - | $ | 655,407 | |||||
Common stock issued in settlement of convertible note and interest | $ | - | $ | 2,236,907 | |||||
Fair value of options issued to acquire management control of variable interest entity | $ | - | $ | 3,226,427 | |||||
FIRST CHOICE HEATLHCARE SOLUTIONS, INC. | |||||||||||||
RECONCILIATION OF NON-GAAP ADJUSTED EBITDA PERFORMANCE | |||||||||||||
(Unaudited) | |||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||
2016 | 2015 | 2016 | 2015 | ||||||||||
Net Income Attributable to FCHS | $ | 544,940 | $ | 631,281 | $ | 10,265,018 | $ | 165,241 | |||||
Gain on sale of property and improvements | - | - | (9,212,346 | ) | - | ||||||||
Depreciation and amortization | 195,822 | 273,263 | 631,571 | 558,189 | |||||||||
Amortization of financing costs | - | 20,592 | 15,654 | 60,507 | |||||||||
Bad debt expense | 319,319 | - | 849,037 | 51,485 | |||||||||
Stock-based compensation | 322,158 | 720,241 | 720,174 | 859,991 | |||||||||
Interest expense, net | 56,560 | 202,907 | 288,748 | 925,045 | |||||||||
Adjusted EBITDA | $ | 1,438,799 | $ | 1,848,284 | $ | 3,557,856 | $ | 2,620,458 | |||||
About First Choice Healthcare Solutions, Inc.
Headquartered in Melbourne, Florida, First Choice Healthcare Solutions (FCHS) is implementing a defined growth strategy aimed at expanding its network of non-physician-owned medical centers of excellence, which concentrate on treating patients in the following specialties: Orthopaedics, Spine Surgery, Neurology, Interventional Pain Management and related diagnostic and ancillary services in key expansion markets throughout the Southeastern U.S. Serving Florida's Space Coast, the Company's flagship integrated platform currently administers over 100,000 patient visits each year and is comprised of First Choice Medical Group, The B.A.C.K. Center and Crane Creek Surgery Center. For more information, please visit www.myfchs.com, www.myfcmg.com, www.thebackcenter.net and www.cranecreeksurgerycenter.com.
Safe Harbor Statement
Certain information set forth in this news announcement may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of First Choice Healthcare Solutions, Inc. Such forward-looking statements are based on current expectations, estimates and projections about the Company's industry, management beliefs and certain assumptions made by its management. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Information concerning factors that could cause the Company's actual results to differ materially from those contained in these forward-looking statements can be found in the Company's periodic reports on Form 10-K and Form 10-Q, and in its Current Reports on Form 8-K, filed with the Securities and Exchange Commission. Unless required by law, the Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise to reflect future events or circumstances or reflect the occurrence of unanticipated events.
Contact Information:
Investor Contact:
Wolfe Axelrod Weinberger Associates
Donald C. Weinberger
don@wolfeaxelrod.com
Stephen D. Axelrod, CFA
steve@wolfeaxelrod.com
Phone: 212-370-4505
At First Choice Healthcare Solutions, Inc.
Phone: 321-802-5830
Email: IR@myfchs.com